Novavax Inc. (NVV1.F)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
9.23
0.14 (1.57%)
At close: Jan 24, 2025, 4:14 PM
undefined% (undefined)
Bid | n/a |
Market Cap | 1.48B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -2.09 |
PE Ratio (ttm) | -4.42 |
Forward PE | n/a |
Analyst | n/a |
Ask | n/a |
Volume | 2,492 |
Avg. Volume (20D) | 3,404 |
Open | 9.05 |
Previous Close | 9.09 |
Day's Range | 9.03 - 9.23 |
52-Week Range | 3.33 - 23.93 |
Beta | undefined |
About NVV1.F
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical tria...
Industry Biotechnology
Sector Healthcare
IPO Date Feb 1, 2001
Employees 1,543
Stock Exchange XETRA
Ticker Symbol NVV1.F
Website https://www.novavax.com